Credit Suisse Ag Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$144.95 - $152.29 $153,502 - $161,275	-1,059 Reduced 1.98%	52,364 $7.92 Million
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $171,767 - $301,615	-2,066 Reduced 3.72%	53,423 $7.79 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $554,803 - $720,316	5,040 Added 9.99%	55,489 $6.58 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $355,238 - $528,885	3,562 Added 7.6%	50,449 $6.95 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $645,885 - $907,637	6,534 Added 16.19%	46,887 $6.51 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $142,150 - $226,948	2,161 Added 5.66%	40,353 $3.95 Million
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $2.32 Million - $3.33 Million	-36,286 Reduced 48.72%	38,192 $2.61 Million
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $336,021 - $507,311	5,164 Added 7.45%	74,478 $6.38 Million
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $654,104 - $863,608	-11,079 Reduced 13.78%	69,314 $4.51 Million
Q2 2020 Aug 12, 2020	BUY	$29.01 - $74.23 $144,817 - $370,556	4,992 Added 6.62%	80,393 $5.88 Million
Q1 2020 May 13, 2020	SELL	$27.51 - $57.29 $179,557 - $373,931	-6,527 Reduced 7.97%	75,401 $2.57 Million
Q4 2019 Feb 12, 2020	BUY	$40.86 - $57.65 $1.85 Million - $2.62 Million	45,377 Added 124.15%	81,928 $4.46 Million
Q3 2019 Nov 12, 2019	SELL	$37.38 - $49.47 $3.11 Million - $4.12 Million	-83,291 Reduced 69.5%	36,551 $1.53 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $3.88 Million - $6.53 Million	97,437 Added 434.89%	119,842 $5.25 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $37,695 - $58,192	1,092 Added 5.12%	22,405 $1.15 Million
Q4 2018 Feb 13, 2019	SELL	$29.75 - $42.9 $718,313 - $1.04 Million	-24,145 Reduced 53.11%	21,313 $788,000
Q3 2018 Nov 13, 2018	BUY	$32.79 - $43.0 $663,636 - $870,277	20,239 Added 80.25%	45,458 $1.71 Million
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $5,905 - $10,572	250 Added 1.0%	25,219 $997,000
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $332,852 - $511,488	14,800 Added 145.54%	24,969 $643,000
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $53,348 - $92,811	2,610 Added 34.53%	10,169 $274,000
Q3 2017 Nov 14, 2017	BUY	$23.54 - $38.21 $177,938 - $288,829	7,559	7,559 $282,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account